These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 782159

  • 1. Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia.
    Korsgaard S.
    Acta Psychiatr Scand; 1976 Jul; 54(1):17-24. PubMed ID: 782159
    [Abstract] [Full Text] [Related]

  • 2. Effect of baclofen on tardive dyskinesia.
    Gerlach J, Rye T, Kristjansen P.
    Psychopharmacology (Berl); 1978 Mar 01; 56(2):145-51. PubMed ID: 417365
    [Abstract] [Full Text] [Related]

  • 3. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.
    Gerlach J, Thorsen K, Munkvad I.
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar 01; 8(2):51-6. PubMed ID: 788002
    [Abstract] [Full Text] [Related]

  • 4. The relationship between parkinsonism and tardive dyskinesia.
    Gerlach J.
    Am J Psychiatry; 1977 Jul 01; 134(7):781-4. PubMed ID: 869056
    [Abstract] [Full Text] [Related]

  • 5. A double-blind trial of baclofen against placebo in the treatment of schizophrenia.
    Gulmann NC, Bahr B, Andersen B, Eliassen HM.
    Acta Psychiatr Scand; 1976 Oct 01; 54(4):287-93. PubMed ID: 793304
    [Abstract] [Full Text] [Related]

  • 6. A controlled trial of baclofen in children with cerebral palsy.
    Milla PJ, Jackson AD.
    J Int Med Res; 1977 Oct 01; 5(6):398-404. PubMed ID: 338390
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Baclofen treatment in chronic schizophrenia: a clinical trial.
    Bigelow LB, Nasrallah H, Carman J, Gillin JC, Wyatt RJ.
    Am J Psychiatry; 1977 Mar 01; 134(3):318-20. PubMed ID: 320885
    [No Abstract] [Full Text] [Related]

  • 10. Baclofen in Parkinson's disease.
    Lees AJ, Shaw KM, Stern GM.
    J Neurol Neurosurg Psychiatry; 1978 Aug 01; 41(8):707-8. PubMed ID: 355602
    [Abstract] [Full Text] [Related]

  • 11. Clonazepam, baclofen and placebo in the treatment of spasticity.
    Cendrowski W, Sobczyk W.
    Eur Neurol; 1977 Aug 01; 16(1-6):257-62. PubMed ID: 354938
    [Abstract] [Full Text] [Related]

  • 12. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E, Christodoulides H.
    Acta Psychiatr Belg; 1975 Jan 01; 75(1):19-32. PubMed ID: 785948
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The treatment of tardive dyskinesia with baclofen.
    Glazer WM, Moore DC, Bowers MB, Bunney BS, Roffman M.
    Psychopharmacology (Berl); 1985 Jan 01; 87(4):480-3. PubMed ID: 3936106
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment.
    Gerlach J, Thorsen K.
    Int Pharmacopsychiatry; 1976 Jan 01; 11(1):1-7. PubMed ID: 770362
    [Abstract] [Full Text] [Related]

  • 17. Methylphenidate in tardive dyskinesia.
    Fann WE, Davis JM, Wilson IC.
    Am J Psychiatry; 1973 Aug 01; 130(8):922-4. PubMed ID: 4577471
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul 01; 27(1):100-3. PubMed ID: 4555826
    [No Abstract] [Full Text] [Related]

  • 19. Effect of cholinergic and anticholinergic agents on tardive dyskinesia.
    Klawans HL, Rubovits R.
    J Neurol Neurosurg Psychiatry; 1974 Aug 01; 37(8):941-7. PubMed ID: 4418481
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.